(Q46178857)

English

Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

0 references

author name string

Juanita M Crook

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

Shawn Malone

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

Gad Perry

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

Libni Eapen

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

Julie Owen

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

Susan Robertson

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

Charles Ludgate

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

Sharon Fung

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

Gina Lockwood

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

language of work or name

0 references

publication date

1 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

115

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

673-679

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

21 January 2018

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

21 January 2018

Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

21 January 2018

The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

21 January 2018

Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysing and interpreting competing risk data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

Dealing with competing risks: testing covariates and calculating sample size

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of localized prostate cancer treated to 75.6Gy with 3D conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of local failure following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytologic regression grading of hormone-treated prostatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24020

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24020

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19117039

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46178857&oldid=2098488223"